{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:59:26Z","timestamp":1781924366104,"version":"3.54.5"},"reference-count":25,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"unspecified","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,4,29]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Long-term maintenance steroid therapy (MST) is often necessary for repeated relapses of chronic eosinophilic pneumonia (CEP). Because relapse does not indicate a worse prognosis, determining the optimal steroid dose to avoid overtreatment presents a clinical challenge. Our primary objective was to evaluate the optimal MST dose to prevent repeated relapses, and the secondary objectives included identifying serum eosinophil count at relapse and background factors of relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicentre retrospective study was conducted on patients with steroid-treated CEP. Background characteristics were compared between the non-relapse and relapse groups. The optimal MST dose was determined based on dose at relapse and the final relapse prevention dose. Additionally, serum eosinophil count at relapse was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 79 patients were included, with 44 in the non-relapse group and 35 in the relapse group. The prednisolone doses required to achieve relapse-free rates of 50% (ED\n                      <jats:sub>50<\/jats:sub>\n                      ) were 7.2\u2009mg (95% CI, 4.6 to 23.6). The median serum eosinophil count at relapse was 1125\u2009\/\u00b5L (IQR, 735\u20132108). No clinically significant background factors were identified between the non-relapse and relapse groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrated that a prednisolone dose of 7.2\u2009mg achieved a 50% relapse-free rate in the relapse group. Based on these findings, we encourage clinicians to evaluate individual minimum effective steroid doses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-002697","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T09:50:15Z","timestamp":1747389015000},"page":"e002697","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Optimal dose of maintenance steroid therapy for relapse of chronic eosinophilic pneumonia: a multicentre retrospective study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1264-0227","authenticated-orcid":false,"given":"Kenichiro","family":"Atsumi","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine and Medical Oncology, Nippon Medical School Tama Nagayama Hospital, Tama-shi, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Nishima","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Medical Oncology, Nippon Medical School Tama Nagayama Hospital, Tama-shi, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kamio","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namiko","family":"Taniuchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nippon Medical School Musashi Kosugi Hospital, Kawasaki-shi, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nippon Medical School Musashi Kosugi Hospital, Kawasaki-shi, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nippon Medical School Chiba Hokusoh Hospital, Inba-gun, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Okano","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nippon Medical School Chiba Hokusoh Hospital, Inba-gun, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Seike","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Medical Oncology, Nippon Medical School Tama Nagayama Hospital, Tama-shi, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"2026010701504501000_12.1.e002697.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196904102801501"},{"key":"2026010701504501000_12.1.e002697.2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.alit.2019.05.006","article-title":"Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management","volume":"68","author":"Suzuki","year":"2019","journal-title":"Allergol Int"},{"key":"2026010701504501000_12.1.e002697.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00085603"},{"key":"2026010701504501000_12.1.e002697.4","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.2169\/internalmedicine.55.6765","article-title":"The Long-term Clinical Course of Chronic Eosinophilic Pneumonia","volume":"55","author":"Ishiguro","year":"2016","journal-title":"Intern Med"},{"key":"2026010701504501000_12.1.e002697.5","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.21037\/jtd-22-511","article-title":"Predictive factors for relapse in corticosteroid-treated patients with chronic eosinophilic pneumonia","volume":"14","author":"Takeuchi","year":"2022","journal-title":"J Thorac Dis"},{"key":"2026010701504501000_12.1.e002697.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00199614"},{"key":"2026010701504501000_12.1.e002697.7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.anai.2017.08.009","article-title":"Persistent impairment on spirometry in chronic eosinophilic pneumonia: A longitudinal observation study (Shizuoka-CEP study)","volume":"119","author":"Suzuki","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026010701504501000_12.1.e002697.8","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10020286"},{"key":"2026010701504501000_12.1.e002697.9","first-page":"299","article-title":"Idiopathic Chronic Eosinophilic Pneumonia: A Clinical and Follow-Up Study of 62 Cases","volume":"77","author":"Marchand","year":"1998","journal-title":"Medicine (Abingdon)"},{"key":"2026010701504501000_12.1.e002697.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.1.162"},{"key":"2026010701504501000_12.1.e002697.11","first-page":"851","article-title":"Chronic eosinophilic pneumonia--a follow-up study of 12 cases","volume":"40","author":"Mochizuki","year":"2002","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2026010701504501000_12.1.e002697.12","doi-asserted-by":"crossref","first-page":"107390","DOI":"10.1016\/j.rmed.2023.107390","article-title":"Minimal effective dose of maintenance steroid therapy for relapse of cryptogenic organizing pneumonia","volume":"218","author":"Atsumi","year":"2023","journal-title":"Respir Med"},{"key":"2026010701504501000_12.1.e002697.13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.metabol.2016.12.001","article-title":"Antecedent longitudinal changes in body mass index are associated with diurnal cortisol curve features: The multi-ethnic study of atherosclerosis","volume":"68","author":"Joseph","year":"2017","journal-title":"Metab Clin Exp"},{"key":"2026010701504501000_12.1.e002697.14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.100008"},{"key":"2026010701504501000_12.1.e002697.15","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.6.993"},{"key":"2026010701504501000_12.1.e002697.16","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1594"},{"key":"2026010701504501000_12.1.e002697.17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200702"},{"key":"2026010701504501000_12.1.e002697.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.038638"},{"key":"2026010701504501000_12.1.e002697.19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew344"},{"key":"2026010701504501000_12.1.e002697.20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221957"},{"key":"2026010701504501000_12.1.e002697.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-024-02868-3","article-title":"Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review","volume":"24","author":"Murillo","year":"2024","journal-title":"BMC Pulm Med"},{"key":"2026010701504501000_12.1.e002697.22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.94.07081541"},{"key":"2026010701504501000_12.1.e002697.23","article-title":"Idiopathic Chronic Eosinophilic Pneumonia Evolving to Pulmonary Fibrosis: A Retrospective Analysis","volume":"39","author":"Baqir","year":"2022","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026010701504501000_12.1.e002697.24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.chest.2015.11.012","article-title":"Airway Surfactant Protein D Deficiency in Adults With Severe Asthma","volume":"149","author":"Mackay","year":"2016","journal-title":"Chest"},{"key":"2026010701504501000_12.1.e002697.25","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.44.811"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-002697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:51:37Z","timestamp":1767779497000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-002697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,16]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjresp-2024-002697"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-002697","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}